zy3637
Lv4
420 积分
2021-04-25 加入
-
History, presence, and future of mitomycin C in glaucoma filtration surgery
10天前
已完结
-
Are all the IL-23 blockers the same in inflammatory bowel disease?
12天前
已完结
-
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
13天前
已完结
-
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
18天前
已完结
-
Activators of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer
23天前
已完结
-
Clazosentan: First Approval
1个月前
已完结
-
How personalized cancer vaccines could keep tumours from coming back
2个月前
已完结
-
Autoimmune diseases: targets, biology, and drug discovery
2个月前
已完结
-
Research Advances in Epidemiology of Autoimmune Diseases in China
2个月前
已完结
-
Navigating the complexities of drug development for inflammatory bowel disease
2个月前
已完结